The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISLB 2022 | Potential of liquid biopsy as a monitoring tool
Adam Widman, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses the current and future applications of liquid biopsy as a monitoring tool and highlights its use as a non-invasive tool to help with ongoing treatment decisions. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
